Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
In recent trading, shares of XP Inc (Symbol: XP) have crossed above the average analyst 12-month target price of $27.00, changing hands for $27.90/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or
To become a "Dividend Aristocrat," a dividend paying company must accomplish an incredible feat: consistently increase shareholder dividends every year for at least 20 consecutive years. Companies with this kind of track record tend to attract a lot of investor attention — an
In recent trading, shares of GDS Holdings Ltd (Symbol: GDS) have crossed above the average analyst 12-month target price of $61.94, changing hands for $62.45/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on va
Norwegian Cruise Line (NCLH) came out with a quarterly loss of $0.99 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to earnings of $0.83 per share a year ago. These figures are adjusted for non-recurring items.
Vascular Biogenics (VBLT) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.12 per share a year ago. These figures are adjusted for non-recurring items.
As of late, it has definitely been a great time to be an investor in Aquestive Therapeutics, Inc. AQST. The stock has moved higher by 46.8% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could s
Deutsche Bank DB is planning to invest €200 billion in sustainable business activities, mainly environmental, social and governance (ESG), by the end of 2025.
A rally in financials led the rebound for U.S. stock indexes, with American Express and JPMorgan Chase helping the Dow Jones Industrial Average break a three-day losing streak.
Another nearly three million people filed for unemployment benefits in the latest week. Tension between the U.S. and China is hurting sentiment as well.
Tougher scrutiny of foreign investment in India has soured the plans of China's smartphone manufacturers seeking to expand beyond selling hardware for a bigger share of the South Asian country's competitive financial services market.
A lightning-quick rally in U.S. equities is showing cracks, as investors face mounting evidence that the economy's coronavirus-fueled woes may be far longer-lasting than many had anticipated.
The Federal Reserve's pledged support for exchange-traded funds may not end up costing the central bank much, but will still have the desired effect of keeping the credit market afloat.
Sentiment toward most Asian currencies turned less bearish, a Reuters poll showed, as a decline in new coronavirus cases prompted some countries to reopen their economies, but investors doubled down on short bets on the Chinese yuan.
Turkey's industrial production output is expected to have expanded 1.8% annually in March, relatively limited growth compared to previous months that reflects the initial economic impact of the coronavirus outbreak.
Oceaneering International (OII) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.19 per share. This compares to loss of $0.24 per share a year ago. These figures are adjusted for non-recurring items.
Checked
26 minutes 40 seconds ago
This feed is responsible for generating the rss feed related to the topic Stocks